RECRUITING

Triple Negative Breast Cancer and Germline Hereditary Breast and Ovarian Cancer Mutation Carrier Registry

Talk to us

Conditions

Breast CancerHereditary Breast and Ovarian CancerTriple Negative Breast CancerTNBCHBOCProspective Registry

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

PROGECT is a registry for patients with Triple Negative breast cancer (TNBC) or patients who have an identified germline mutations (such as a mutation on the BRCA1 or BRCA2 genes).

Official Title

PROspective Evaluation of GErmline Mutations, Cancer Outcome and Tissue Biomarkers: A Registry for Patients With Triple Negative Breast Cancer and Germline Mutations

Quick Facts

Study Start:2011-03-22
Study Completion:2025-12
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT02302742

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:Not specified
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:CHILD, ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. Age 18 years or older
  2. Willing and able to provide informed consent
  3. Able to understand and follow study procedures
  4. Stable medical condition
  1. Pregnancy or breastfeeding
  2. Severe psychiatric disorders
  3. Active substance abuse
  4. Unstable medical conditions
  5. Inability to comply with study requirements

Contacts and Locations

Study Contact

Joshua Staley
CONTACT
913-588-8548
jstaley2@kumc.edu

Principal Investigator

Priyanka Sharma, MD
PRINCIPAL_INVESTIGATOR
The University of Kansas Medical Center

Study Locations (Sites)

Hays Medical Center Dreiling-Schmidt Cancer Institute
Hays, Kansas, 67601
United States
KCCC West
Kansas City, Kansas, 66112
United States
Menorah Medical Center
Overland Park, Kansas, 66209
United States
KCCC Overland Park
Overland Park, Kansas, 66210
United States
Overland Park Regional Medical Center
Overland Park, Kansas, 66215
United States
Salina Regional Health Center - Tammy Walker Cancer Center
Salina, Kansas, 67401
United States
The University of Kansas Cancer Center
Westwood, Kansas, 66205
United States
Centerpoint Regional Medical Center
Independence, Missouri, 64057
United States
Truman Medical Center
Kansas City, Missouri, 64108
United States
KCCC South
Kansas City, Missouri, 64131
United States
Research Medical Center
Kansas City, Missouri, 64132
United States
KCCC - North
Kansas City, Missouri, 64154
United States
KCCC Lee's Summit
Lee's Summit, Missouri, 64064
United States

Collaborators and Investigators

Sponsor: University of Kansas Medical Center

  • Priyanka Sharma, MD, PRINCIPAL_INVESTIGATOR, The University of Kansas Medical Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2011-03-22
Study Completion Date2025-12

Study Record Updates

Study Start Date2011-03-22
Study Completion Date2025-12

Terms related to this study

Keywords Provided by Researchers

  • Triple Negative Breast Cancer
  • TNBC
  • Hereditary Breast and Ovarian Cancer
  • HBOC
  • Prospective Registry

Additional Relevant MeSH Terms

  • Breast Cancer
  • Hereditary Breast and Ovarian Cancer